E-LIB Suche - Ergebnisse für: Medori, Rossella

1

A Randomized, Double‐Blind, Controlled Phase II Study of Fo..:

Rascol, Olivier ; Medori, Rossella ; Baayen, Corine...
Movement Disorders. 37 (2022) 5 - p. 1088-1093 , 2022

Link: https://doi.org/10.1002/..

2

Safety and Tolerability of Active Immunotherapy Targeting α..:

Poewe, Werner ; Volc, Dieter ; Seppi, Klaus...
Journal of Parkinson's Disease. 11 (2021) 3 - p. 1079-1089 , 2021

Link: https://doi.org/10.3233/..

3

A phase I study assessing the safety, tolerability, immunog..:

Zeitlinger, Markus ; Bauer, Martin ; Reindl-Schwaighofer, Roman...
European Journal of Clinical Pharmacology. 77 (2021) 10 - p. 1473-1484 , 2021

Link: https://doi.org/10.1007/..

4

A Phase 1 Randomized Trial of Specific Active α‐Synuclein I..:

Meissner, Wassilios G. ; Traon, Anne Pavy‐Le ; Foubert‐Samier, Alexandra...
Movement Disorders. 35 (2020) 11 - p. 1957-1965 , 2020

Link: https://doi.org/10.1002/..

5

An mGlu4‐Positive Allosteric Modulator Alleviates Parkinson..:

Charvin, Delphine ; Di Paolo, Therese ; Bezard, Erwan...
Movement Disorders. 33 (2018) 10 - p. 1619-1631 , 2018

Link: https://doi.org/10.1002/..

6

Assessing clinical correlates of self-rated disability in p..:

Magistrale, Giuseppe ; Medori, Rossella ; Cadavid, Diego...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1 (2015) - p. 205521731559242 , 2015

Link: https://doi.org/10.1177/..

7

Prolonged-release fampridine and walking and balance in MS:..:

Hupperts, Raymond ; Lycke, Jan ; Short, Christine...
Multiple Sclerosis Journal. 22 (2015) 2 - p. 212-221 , 2015

Link: https://doi.org/10.1177/..

8

Validation of the World Health Organization Disability Asse..:

Magistrale, Giuseppe ; Pisani, Valerio ; Argento, Ornella...
Multiple Sclerosis Journal. 21 (2014) 4 - p. 448-456 , 2014

Link: https://doi.org/10.1177/..

9

Responder definition of the Multiple Sclerosis Impact Scale..:

Phillips, Glenn A ; Wyrwich, Kathleen W ; Guo, Shien...
Multiple Sclerosis Journal. 20 (2014) 13 - p. 1753-1760 , 2014

Link: https://doi.org/10.1177/..

10

Treating attention-deficit/hyperactivity disorder beyond sy..:

Buitelaar, Jan ; Medori, Rossella
European Child & Adolescent Psychiatry. 19 (2009) 4 - p. 325-340 , 2009

Link: https://doi.org/10.1007/..

11

Treating attention-deficit/hyperactivity disorder beyond sy..:

Buitelaar, Jan ; Medori, Rossella
European Child & Adolescent Psychiatry. 19 (2009) 4 - p. 325-340 , 2009

Link: https://doi.org/10.1007/..

12

ESTABLISHING REMISSION AND GOOD CLINICAL FUNCTIONING IN SCH..:

Lex, Alice ; Naber, Dieter ; De Marinis, Tito..
Schizophrenia Research. 102 (2008) 1-3 - p. 214 , 2008

Link: https://doi.org/10.1016/..

13

ASSESSING THE IMPACT OF POSSIBLE COVERT POOR COMPLIANCE IN ..:

Emsley, Robin ; Oosthuizen, Petrus ; Koen, Liezl...
Schizophrenia Research. 102 (2008) 1-3 - p. 263-264 , 2008

Link: https://doi.org/10.1016/..

14

Concordance of patient and clinical ratings of symptom seve..:

Rabinowitz, Jonathan ; Levine, Stephen Z. ; Medori, Rossella...
Schizophrenia Research. 100 (2008) 1-3 - p. 359-360 , 2008

Link: https://doi.org/10.1016/..

15

A Randomized, Placebo-Controlled Trial of Three Fixed Dosag..:

Medori, Rossella ; Ramos-Quiroga, J. Antoni ; Casas, Miguel...
Biological Psychiatry. 63 (2008) 10 - p. 981-989 , 2008

Link: https://doi.org/10.1016/..